Back to Search
Start Over
IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole.
- Source :
- Indian Dermatology Online Journal; Jan/Feb2024, Vol. 15 Issue 1, p1-7, 7p
- Publication Year :
- 2024
-
Abstract
- Itraconazole (ITZ) has been the mainstay of oral antifungal treatment for the current epidemic of recalcitrant dermatophytosis (RD) in India. Recently, a newer formulation of ITZ, super bioavailable itraconazole (SUBA-ITZ), is made available in the market by many pharmaceutical companies. It is important for dermatologists to understand the pharmacokinetic properties of SUBA-ITZ vis-a-vis conventional pellet formulation to use it effectively and safely. Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) has established a special interest group for recalcitrant dermatophytosis (SIG-RD) to strengthen research, continuing medical education, and industry collaboration on the subject. This position statement on SUBA-ITZ by SIG-RD is an attempt to address current pieces of evidence and the position of this new formulation in the management of RD. [ABSTRACT FROM AUTHOR]
- Subjects :
- RINGWORM
ITRACONAZOLE
CONTINUING medical education
ORAL drug administration
Subjects
Details
- Language :
- English
- ISSN :
- 22295178
- Volume :
- 15
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Indian Dermatology Online Journal
- Publication Type :
- Academic Journal
- Accession number :
- 175581030
- Full Text :
- https://doi.org/10.4103/idoj.idoj_668_22